HIPAA Omnibus Rule: Part 5 (Privacy Rule Changes)

The HIPAA / HITECH Privacy Rule has been changed.Under the Modifications to the HIPAA Privacy, Security, Enforcement, and Breach Notification Rules under the Health Information Technology for [...]

HIPAA Omnibus Rule: Part 4 (Security Rule Changes)

The Modifications to the HIPAA Privacy, Security, Enforcement, and Breach Notification Rules under the Health Information Technology for Economic and Clinical Health Act and the Genetic [...]

HIPAA Omnibus Rule: Part 3 (Enforcement & Penalties)

The Modifications to the HIPAA Privacy, Security, Enforcement, and Breach Notification Rules under the Health Information Technology for Economic and Clinical Health Act and the Genetic [...]

HIPAA Omnibus Rule: Part 2 (Business Associates & Subcontractors)

Business Associates and subcontractors have expanded obligations under the Omnibus Rule.

HIPAA Omibus Rule: Part 1 (Overview)

The Department of Health and Human Services Office for Civil Rights (OCR) released its final rule, Modifications to the HIPAA Privacy, Security, Enforcement, and Breach Notification Rules under [...]

New HHS Rule Protects Patient Privacy Under HIPAA and HITECH

Much-anticipated regulation protects patient privacy under HIPAA and HITECH

Is it fee-splitting to share profits in an acupuncture, chiropractic, osteopathic, or MD physician group?

An acupuncture student from Northern California wrote in asking the following question about fee-splitting, kickbacks, Stark / self-referral, and group practices.

Off-label drug promotion and marketing yields significant penalties: Part 2 (Misbranding in interstate commerce)

Misbranding can also occur when a product is "held for sale after shipment in interstate commerce.

Off-label drug promotion and marketing yields significant penalties: Part 1 (Amgen settlement)

Off-label drug use is not illegal, but off-label drug promotion and marketing can result in significant legal penalties.

Weight Loss Advertisements Found Deceptive and Misleading – Conspiracy and Healthcare Fraud Violations

The 1-800-GET-THIN ad campaign is embroiled in a criminal investigation for healthcare fraud and other violationsThe FDA and FBI are investigating.